Explanipedia

Expected Surgical Risk and the Risk of Stroke and Brain Injury After Transcatheter Aortic Valve Replacement: A Patient-Level Pooled Analysis Open

Steven R. Messé, Daniel Grubman, Mary E. Huerter, Michael G. Dwyer, Robert Zivadinov , et al. · 2025

Is Egg Ready to Leave the Nest and Fly? Open

Natalija Odanovic, Pedro Engel Gonzalez, Amit N. Vora · 2025

Variability in State-Level Regulations Regarding Occupational Radiation Exposure Open

Amit N. Vora, James Hermiller, Rahul Gupta, Andrew M. Goldsweig, Georges Ephrem , et al. · 2025

Preventing cerebrovascular events in patients undergoing TAVR: the current and future landscape Open

Ahmed Ss, Amit N. Vora, Tayyab Shah, Alexandra J. Lansky · 2025

In-Hospital Outcomes and 30-Day Readmission Rate After Transcatheter and Surgical Aortic Valve Replacement in Liver Cirrhosis: A Contemporary Propensity-Matched Analysis Open

Abhinav Aggarwal, Sun-Joo Jang, Swarnima Vardhan, Fabrício Malaguez Webber, Md. Mashiul Alam , et al. · 2024

TAVR is associated with significantly lower rates of in-hospital mortality, bleeding, vascular complications, hepatorenal syndrome, cardiogenic shock, mechanical circulatory support utilization, and 30-day readmission rates compared to SAV…

Breaking Down Barriers to Transcatheter Aortic Valve Replacement Open

Amit N. Vora, Wayne Batchelor, Konstantinos Dean Boudoulas, Ramesh Daggubati, Sammy Elmariah , et al. · 2024

The Current Landscape of Transcatheter Tricuspid Valve Intervention Open

Henry Seligman, Amit N. Vora, Noah Q. Haroian, Rishi Puri, Ee Ling Heng , et al. · 2023

Tricuspid regurgitation (TR) is common, and its prevalence increases with age. It was previously estimated that there are 1.6 million patients in the United States with moderate or worse TR, and more contemporary data suggest the age-adjus…

A Multimodality Video-Based AI Biomarker For Aortic Stenosis Development And Progression Open

Evangelos K. Oikonomou, Gregory Holste, Neal Yuan, Andreas Coppi, Robert L. McNamara , et al. · 2023

Importance Aortic stenosis (AS) is a major public health challenge with a growing therapeutic landscape, but current biomarkers do not inform personalized screening and follow-up. Objective A video-based artificial intelligence (AI) biomar…

Transcarotid versus transaxillary access for transcatheter aortic valve replacement with a self-expanding valve: A propensity-matched analysis Open

Keith B. Allen, Daniel Watson, Amit N. Vora, Paul Mahoney, Adnan K. Chhatriwalla , et al. · 2023

Right ventricular-pulmonary arterial coupling in patients with COVID-19: A systematic review and meta-analysis Open

Amit N. Vora, Layth Al Tmimi, Dieter Van Beersel, Steffen Rex · 2023

Objectives: In this systematic review and meta-analysis, we assessed the association between right ventricular-pulmonary arterial (RV-PA) coupling and mortality in coronavirus disease 2019 (COVID-19). Methods: We performed a systematic lit…

Clinical Impact of Standardized TAVR Technique and Care Pathway Open

Kendra J. Grubb, Hemal Gada, Suneet Mittal, Tamim Nazif, Josep Rodés‐Cabau , et al. · 2023

The use of the TAVR care pathway and COT resulted in favorable clinical outcomes with no moderate or severe AR and low PPI rates at 30 days while facilitating early discharge and reproducible outcomes across various sites and operators. (O…

Effect of COVID-19 Surveillance Testing on Patient Perceptions in Outpatients Undergoing Cardiovascular Procedures: Results From the Restoring Non-Emergent Cardiovascular Care in the Peri-COVID-19 Era (RECIPE) Registry Open

Stephen R. Bruening, Amit N. Vora, Hemal Gada, Chinmay Patel, Torrey Schmidt , et al. · 2022

Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke Open

M. Cecilia Bahit, Amit N. Vora, Zhuokai Li, Daniel Wojdyla, Laine Thomas , et al. · 2022

ClinicalTrials.gov Identifier: NCT02415400.

Transcatheter Aortic Valve Replacement Optimization Strategies: Cusp Overlap, Commissural Alignment, Sizing, and Positioning Open

Saima Siddique, Resha Khanal, Amit N. Vora, Hemal Gada · 2022

As transcatheter aortic valve replacement (TAVR) rapidly expands to younger patients and those at low surgical risk, there is a compelling need to identify patients at increased risk of post-procedural complications, such as paravalvular l…

Non-vitamin K antagonist oral anticoagulants in patients with valvular heart disease Open

Alexander C. Fanaroff, Amit N. Vora, Renato D. Lópes · 2022

The non-vitamin K antagonist oral anticoagulants (NOACs) dabigatran, rivaroxaban, apixaban, and edoxaban have transformed the management of atrial fibrillation (AF), but are only approved by regulatory authorities for stroke prophylaxis in…

Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial Open

Robert C. Welsh, Payam Dehghani, Renato D. Lópes, Daniel Wojdyla, Ronald Aronson , et al. · 2022

Objective Managing antithrombotic therapy in patients with atrial fibrillation (AF) and an acute coronary syndrome (ACS) and/or percutaneous coronary intervention (PCI) is challenging and can be affected by prior oral anticoagulant (OAC) t…

Transcatheter aortic valve replacement associated infective endocarditis case series: broadening the criteria for diagnosis is the need of the hour Open

Kriti Lnu, Shamim Akhtar Ansari, Shantanu Mahto, Hemal Gada, Mubashir Mumtaz , et al. · 2021

Background Transcatheter valve replacement (TAVR) is an important therapeutic intervention for patients with aortic valve stenosis. As TAVR has become available to a broader population, there has been an increase in the number of less comm…

Variation in Antithrombotic Therapy and Clinical Outcomes in Patients With Preexisting Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement Open

Matthew W. Sherwood, Aakriti Gupta, Sreekanth Vemulapalli, Zhuokai Li, Jonathan P. Piccini , et al. · 2021

Background: Optimal antithrombotic management of patients with preexisting atrial fibrillation undergoing transcatheter aortic valve replacement is challenging given the need to balance the risk of bleeding and thromboembolism. We aimed to…

Staying in the Shallow End Open

Amit N. Vora, Hemal Gada · 2021

Additional file 6 of Transcatheter aortic valve replacement associated infective endocarditis case series: broadening the criteria for diagnosis is the need of the hour Open

Kriti Lnu, Shamim Akhtar Ansari, Shantanu Mahto, Hemal Gada, Mubashir Mumtaz , et al. · 2021

Additional file 6: Table S1.

Transcatheter Approaches to Aortic Insufficiency Open

Saima Siddique, Amit N. Vora, Hemal Gada · 2020

Is Transcatheter Aortic Valve Replacement Worth the Wait? Open

Matthew W. Sherwood, Amit N. Vora · 2020

Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention Open

John H. Alexander, Daniel Wojdyla, Amit N. Vora, Laine Thomas, Christopher B. Granger , et al. · 2020

Background: In AUGUSTUS (Open-Label, 2×2 Factorial, Randomized, Controlled Clinical Trial to Evaluate the Safety of Apixaban vs Vitamin K Antagonist and Aspirin vs Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syn…

Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin Open

Amit N. Vora, John H. Alexander, Daniel Wojdyla, Ronald Aronson, Christopher B. Granger , et al. · 2019

atrial fibrillation ◼ hospitalization ◼ percutaneous coronary intervention ◼ platelet aggregation inhibitors T he optimal antithrombotic therapy among patients with atrial fibrillation who present with acute coronary syndrome (ACS) or requ…

Valve-in-Ring Transcatheter Aortic Valve Replacement After Left Ventricular Assist Device Therapy Open

Matthew Chung, Asvin M. Ganapathi, Amit N. Vora, Jacob N. Schroder, Todd L. Kiefer , et al. · 2019

Bleeding Complications in Lower-Extremity Peripheral Vascular Interventions Open

Bhaskar Bhardwaj, John A. Spertus, Kevin F. Kennedy, W. Schuyler Jones, David M. Safley , et al. · 2019

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation Open

Renato D. Lópes, Gretchen Heizer, Ronald Aronson, Amit N. Vora, Tyler Massaro , et al. · 2019

In patients with atrial fibrillation and a recent acute coronary syndrome or PCI treated with a P2Y₁₂ inhibitor, an antithrombotic regimen that included apixaban, without aspirin, resulted in less bleeding and fewer hospitalizat…

IHRS President's page Open

Amit N. Vora · 2018

Percutaneous or surgical access for transfemoral transcatheter aortic valve implantation Open

Amit N. Vora, Sunil V. Rao · 2018

Transcatheter aortic valve implantation is an important therapeutic option for patients with symptomatic, severe aortic stenosis at increased risk for open surgical aortic valve replacement. Although a number of alternative vascular access…

First‐in‐human experience with Aortix intraaortic pump Open

Amit N. Vora, W. Schuyler Jones, Adam D. DeVore, Adrián Ebner, William Clifton , et al. · 2018

Background There are limited options for percutaneous mechanical circulatory support (pMCS) in patients requiring high‐risk percutaneous coronary intervention. Objectives This first‐in‐human, single‐center study aimed to evaluate the safet…

Amit N. Vora YOU? Author Swipe